Your browser doesn't support javascript.
loading
Leveraging IFNγ/CD38 regulation to unmask and target leukemia stem cells in acute myelogenous leukemia.
Murtadha, Mariam; Park, Miso; Zhu, Yinghui; Caserta, Enrico; Dona, Ada Alice; Singer, Mahmoud; Vahed, Hawa; Tasndoh, Theophilus; Gonzalez, Asaul; Ly, Kevin; Sanchez, James F; Chowdhury, Arnab; Pozhitkov, Alex; Ghoda, Lucy; Li, Ling; Zhang, Bin; Krishnan, Amrita; Marcucci, Guido; Williams, John; Pichiorri, Flavia.
Afiliação
  • Murtadha M; Judy and Bernard Briskin Center for Multiple Myeloma Research, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope; Duarte, CA, USA.
  • Park M; Department of Hematologic Malignancies Translational Science, Beckman Research Institute, City of Hope; Duarte, CA, USA.
  • Zhu Y; Department of Molecular Medicine, Beckman Research Institute, City of Hope; Duarte, CA, USA.
  • Caserta E; Judy and Bernard Briskin Center for Multiple Myeloma Research, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope; Duarte, CA, USA.
  • Dona AA; Department of Hematologic Malignancies Translational Science, Beckman Research Institute, City of Hope; Duarte, CA, USA.
  • Singer M; Judy and Bernard Briskin Center for Multiple Myeloma Research, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope; Duarte, CA, USA.
  • Vahed H; Department of Hematologic Malignancies Translational Science, Beckman Research Institute, City of Hope; Duarte, CA, USA.
  • Tasndoh T; Judy and Bernard Briskin Center for Multiple Myeloma Research, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope; Duarte, CA, USA.
  • Gonzalez A; Department of Hematologic Malignancies Translational Science, Beckman Research Institute, City of Hope; Duarte, CA, USA.
  • Ly K; Judy and Bernard Briskin Center for Multiple Myeloma Research, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope; Duarte, CA, USA.
  • Sanchez JF; Department of Hematologic Malignancies Translational Science, Beckman Research Institute, City of Hope; Duarte, CA, USA.
  • Chowdhury A; Judy and Bernard Briskin Center for Multiple Myeloma Research, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope; Duarte, CA, USA.
  • Pozhitkov A; Department of Hematologic Malignancies Translational Science, Beckman Research Institute, City of Hope; Duarte, CA, USA.
  • Ghoda L; Judy and Bernard Briskin Center for Multiple Myeloma Research, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope; Duarte, CA, USA.
  • Li L; Department of Hematologic Malignancies Translational Science, Beckman Research Institute, City of Hope; Duarte, CA, USA.
  • Zhang B; Department of Molecular Medicine, Beckman Research Institute, City of Hope; Duarte, CA, USA.
  • Krishnan A; Department of Molecular Medicine, Beckman Research Institute, City of Hope; Duarte, CA, USA.
  • Marcucci G; Judy and Bernard Briskin Center for Multiple Myeloma Research, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope; Duarte, CA, USA.
  • Williams J; Judy and Bernard Briskin Center for Multiple Myeloma Research, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope; Duarte, CA, USA.
  • Pichiorri F; Department of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope; Duarte, CA, USA.
bioRxiv ; 2023 Mar 01.
Article em En | MEDLINE | ID: mdl-36909542
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BioRxiv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BioRxiv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos